V companies public / 12331
Abcuro
| id | 12331 |
|---|---|
| name | Abcuro |
| category | Biotech / Pharma |
| hq_city | — |
| hq_state | — |
| hq_country | US |
| metro_area | — |
| region | — |
| website | — |
| founded_year | — |
| is_public | false |
| firm_type | — |
| description | [alert] Abcuro raised $66M in Series D funding to advance ulviprubart in an inclusion body myositis trial. NEA participated in the round ... |
| person_count | 0 |
| has_funding | true |
| latest_funding_usd | 66000000.0 |
| nexus_score | — |
| nexus_tier | — |
| updated_at | 2026-08-23T14:46:39.555701+00:00 |